JPRN-UMIN000048395已完成未知
Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cancer Risk: A systematic review and network meta-analysis - Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cancer Risk: A systematic review and network meta-analysis
Yokohama City University Graduate School of Medicine0 个研究点开始时间: 2022年7月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Systematic review or meta-analysis articles. (2) Retrospective analysis. (3) Single prospective cohort study without a control group. (4) Non-RCT. (5) The republished research literature is excluded unless the research includes new findings related to cancers listed in inclusion criteria. (6) Studies with no or insufficient safety outcomes at the time of the literature search. Two investigators independently will screen all titles, abstracts, and full texts for eligibility. Final inclusion will be decided after resolving discrepancies between the two investigators.
研究者
相似试验
招募中
不适用
Angiotensin receptor-neprilysin inhibitor in patients with acute myocardial infarction and heart failureAcute myocardial infarctionJPRN-UMIN000046004Chiba University Hospital1,000
招募中
Unknown
The effect of an angiotensin receptor-neprilysin inhibitor to blood pressure and sympathoadrenal responses during mental arithmetic stress in patients with essential hypertensioessential hypertensionJPRN-UMIN000051537niversity of Toyama40
进行中（未招募）
1 期
Effect of the drug sacubitril/valsartan on physical performance in patients with hypertrophic cardiomyopathyhypertrophic cardiomyopathyEUCTR2018-004882-15-DEniversity Hospital Regensburg40
已完成
不适用
Real-World Evidence of Angiotensin Receptor-Neprilysin Inhibitor in Patients with Heart Failure (REVIEW-HF)Heart FailureJPRN-UMIN000047636Toho University Faculty of Medicine1,000
招募中
1 期
Initiation of angiotensin receptor-neprilysin inhibitor (ARNi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF): the INITIATE-HFrEF randomized open-label trialHeart failure with reduced ejection fractionMedDRA version: 20.0Level: LLTClassification code: 10078289Term: Heart failure with reduced ejection fraction Class: 10007541CTIS2022-502409-14-00niversity Of Porto172